B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Idelalisib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Idelalisib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sapanisertib
5 shared targets
bimiralisib
6 shared targets
duvelisib
4 shared targets
gedatolisib
5 shared targets
omipalisib
6 shared targets
voxtalisib
4 shared targets
vistusertib
5 shared targets
buparlisib
6 shared targets
azd
5 shared targets
zstk
4 shared targets
Loading evidence profile...

This evidence profile for Idelalisib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.